Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05810220 · ClinicalTrials.gov registry record · NA
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
A NA study of Deafness, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05810220: Recruiting NA study of Deafness, sponsored by NYU Langone Health.
NCT05810220 is a NA study of Deafness that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 599-participant average among 11 other Deafness trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05810220, a NA study of Deafness, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.
Primary Outcome
Participants will listen to speech sounds and indicate what sentence or word they heard. The outcome is the percent of speech sounds that are correctly identified.
Conditions Studied
Interventions
- DEVICE Electrode-Neural Interface
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-12-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05810220 shows while recruiting
NCT05810220 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 599-participant average among 11 other Deafness trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Deafness appearing as the primary indexed condition, and to 1 intervention - of which Electrode-Neural Interface is the first listed.
NCT05810220 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05810220 about?
NCT05810220 is a clinical study titled "Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants". This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.
What is the current status of trial NCT05810220?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2018-12-02. Estimated completion is 2026-12.
What conditions does trial NCT05810220 study?
This clinical trial studies the following conditions: Deafness.
What interventions are being tested in trial NCT05810220?
The interventions under investigation include: Electrode-Neural Interface (DEVICE).
Who is sponsoring clinical trial NCT05810220?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05810220 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deafness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05810220's enrollment target sits among peer trials
200 4th of 11 higher than 7 of 11 other Deafness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Deafness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Novel Coding Strategies for Children With Cochlear Implants
RECRUITING · NA
-
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
RECRUITING · NA
-
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
RECRUITING · NA
-
Hearing Program in Primary Care
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI